|
6XDJ
Crystal Structure Analysis of MBP-SIN3
Deposited 2020-06-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
3–360(358 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1M Bis-Tris, pH 6.0, 1.6M Ammonium sulfate
|
Resolution 2.20 Å
R-free 0.240
|
|
6XDJ
Crystal Structure Analysis of MBP-SIN3
Deposited 2020-06-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
3–360(358 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1M Bis-Tris, pH 6.0, 1.6M Ammonium sulfate
|
Resolution 2.20 Å
R-free 0.240
|
|
6XDJ
Crystal Structure Analysis of MBP-SIN3
Deposited 2020-06-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
3–360(358 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1M Bis-Tris, pH 6.0, 1.6M Ammonium sulfate
|
Resolution 2.20 Å
R-free 0.240
|
|
6XDJ
Crystal Structure Analysis of MBP-SIN3
Deposited 2020-06-10
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
3–360(358 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1M Bis-Tris, pH 6.0, 1.6M Ammonium sulfate
|
Resolution 2.20 Å
R-free 0.240
|
|
7FBB
De novo design protein D12 with MBP tag
Deposited 2021-07-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
6–372(367 aa)
|
Mutation:D84A, K85A, E174A, N175A, K241A, E361A, K364A, D365A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;25% PEG 3350, 0.1M Sodium Acetate
|
Resolution 2.31 Å
R-free 0.264
|
|
7FBB
De novo design protein D12 with MBP tag
Deposited 2021-07-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
6–372(367 aa)
|
Mutation:D84A, K85A, E174A, N175A, K241A, E361A, K364A, D365A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;25% PEG 3350, 0.1M Sodium Acetate
|
Resolution 2.31 Å
R-free 0.264
|
|
7FBC
De novo design protein D22 with MBP tag
Deposited 2021-07-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
3–371(369 aa)
|
Mutation:D84A,K85A,E174A,N175A,K241A,E361A,K364A,D365A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.24;289 K;50% v/v PEG 500 MME, 0.1M Sodium HEPES, pH 7.24
|
Resolution 1.85 Å
R-free 0.215
|
|
7FBD
De novo design protein D53 with MBP tag
Deposited 2021-07-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
3–371(369 aa)
|
Mutation:D84A,K85A,E174A,N175A,K241A,E361A,K364A,D365A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;2.2M Sodium malonate pH 7.0
|
Resolution 2.85 Å
R-free 0.277
|
|
7FBD
De novo design protein D53 with MBP tag
Deposited 2021-07-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
3–371(369 aa)
|
Mutation:D84A,K85A,E174A,N175A,K241A,E361A,K364A,D365A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;2.2M Sodium malonate pH 7.0
|
Resolution 2.85 Å
R-free 0.277
|
|
7KD4
Structure of the C-terminal domain of the Menangle virus phosphoprotein (residues 329 -388), fused to MBP. Space group P21.
Deposited 2020-10-08
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
3–372(370 aa)
|
Mutation:C352S
|
SO4 SULFATE ION × 9
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;291.15 K;1.65 M Ammonium sulphate, 0.2M Malic acid/KOH pH 5.5, Crystals were transferred into the following cryo-protective solution before vitrification: 1.65 M Ammonium sulphate, 0.2M Malic acid/KOH pH 5.5, 5mM Maltose, 1 M Lithium sulfate
|
Resolution 1.31 Å
R-free 0.196
|
|
7KD4
Structure of the C-terminal domain of the Menangle virus phosphoprotein (residues 329 -388), fused to MBP. Space group P21.
Deposited 2020-10-08
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
3–372(370 aa)
|
Mutation:C352S
|
SO4 SULFATE ION × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;291.15 K;1.65 M Ammonium sulphate, 0.2M Malic acid/KOH pH 5.5, Crystals were transferred into the following cryo-protective solution before vitrification: 1.65 M Ammonium sulphate, 0.2M Malic acid/KOH pH 5.5, 5mM Maltose, 1 M Lithium sulfate
|
Resolution 1.31 Å
R-free 0.196
|
|
7KD5
Structure of the C-terminal domain of the Menangle virus phosphoprotein (residues 329 -388), fused to MBP. Space group P212121
Deposited 2020-10-08
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
3–372(370 aa)
|
Mutation:C352S
|
EDO 1,2-ETHANEDIOL × 4
PIN PIPERAZINE-N,N'-BIS(2-ETHANESULFONIC ACID) × 3
PRO PROLINE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.7;291.15 K;20%(w/v) PEG 5000 mono-methyl ether, 0.2 M Pipes/KOH pH 6.7, 0.1M Proline, Crystals were transferred into the following cryo-protective solution before vitrification: 20%(w/v) PEG 5000 mono-methyl ether, 0.2 M Pipes/KOH pH 6.7, 0.1M Proline, 5mM Maltose, 20%(v/v) Ethylene Glycol
|
Resolution 1.55 Å
R-free 0.189
|
|
7VN2
Crystal structure of MBP-fused BIL1/BZR1 (21-90) in complex with double-stranded DNA contaning ATCACGTGAT
Deposited 2021-10-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain C
3–370(368 aa)
|
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
|
EDO 1,2-ETHANEDIOL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;50 mM sodium cacodylate pH 6.5, 200 mM potassium chloride, 10 mM magnesium chloride and 10% (w/v) polyethylene glycol (PEG) 4000
|
Resolution 2.42 Å
R-free 0.248
|
|
7VN2
Crystal structure of MBP-fused BIL1/BZR1 (21-90) in complex with double-stranded DNA contaning ATCACGTGAT
Deposited 2021-10-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain A
3–370(368 aa)
|
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
|
EDO 1,2-ETHANEDIOL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;50 mM sodium cacodylate pH 6.5, 200 mM potassium chloride, 10 mM magnesium chloride and 10% (w/v) polyethylene glycol (PEG) 4000
|
Resolution 2.42 Å
R-free 0.248
|
|
7VN3
Crystal structure of MBP-fused BIL1/BZR1 (21-90) in complex with double-stranded DNA contaning CACACGTGTG
Deposited 2021-10-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain C
3–370(368 aa)
Chain D
3–370(368 aa)
|
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
|
EDO 1,2-ETHANEDIOL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;50 mM sodium cacodylate pH 6.5, 200 mM ammonium acetate and 10 mM calcium chloride and 10% (w/v) polyethylene glycol (PEG) 4000
|
Resolution 1.94 Å
R-free 0.231
|
|
7VN3
Crystal structure of MBP-fused BIL1/BZR1 (21-90) in complex with double-stranded DNA contaning CACACGTGTG
Deposited 2021-10-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain A
3–370(368 aa)
Chain B
3–370(368 aa)
|
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
|
EDO 1,2-ETHANEDIOL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;50 mM sodium cacodylate pH 6.5, 200 mM ammonium acetate and 10 mM calcium chloride and 10% (w/v) polyethylene glycol (PEG) 4000
|
Resolution 1.94 Å
R-free 0.231
|
|
7VN4
Crystal structure of MBP-fused BIL1/BZR1 (21-90) in complex with double-stranded DNA contaning TCCACGTGGA
Deposited 2021-10-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain C
3–370(368 aa)
Chain D
3–370(368 aa)
|
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
|
EDO 1,2-ETHANEDIOL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;50 mM sodium cacodylate pH 6.5, 200 mM ammonium acetate and 10 mM calcium chloride and 10% (w/v) polyethylene glycol (PEG) 4000
|
Resolution 2.10 Å
R-free 0.245
|
|
7VN4
Crystal structure of MBP-fused BIL1/BZR1 (21-90) in complex with double-stranded DNA contaning TCCACGTGGA
Deposited 2021-10-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain A
3–370(368 aa)
Chain B
3–370(368 aa)
|
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
|
EDO 1,2-ETHANEDIOL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;50 mM sodium cacodylate pH 6.5, 200 mM ammonium acetate and 10 mM calcium chloride and 10% (w/v) polyethylene glycol (PEG) 4000
|
Resolution 2.10 Å
R-free 0.245
|
|
7VN5
Crystal structure of MBP-fused BIL1/BZR1 (21-90) in complex with double-stranded DNA contaning TTCACGTGAA
Deposited 2021-10-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain C
3–370(368 aa)
Chain D
3–370(368 aa)
|
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
|
EDO 1,2-ETHANEDIOL × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;50 mM sodium cacodylate pH 6.5, 200 mM ammonium acetate and 10 mM calcium chloride and 10%
|
Resolution 1.95 Å
R-free 0.244
|
|
7VN5
Crystal structure of MBP-fused BIL1/BZR1 (21-90) in complex with double-stranded DNA contaning TTCACGTGAA
Deposited 2021-10-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain A
3–370(368 aa)
Chain B
3–370(368 aa)
|
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
|
EDO 1,2-ETHANEDIOL × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;50 mM sodium cacodylate pH 6.5, 200 mM ammonium acetate and 10 mM calcium chloride and 10%
|
Resolution 1.95 Å
R-free 0.244
|
|
7VN6
Crystal structure of MBP-fused BIL1/BZR1 (21-90) in complex with double-stranded DNA contaning CGCACGTGCG
Deposited 2021-10-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain C
3–370(368 aa)
Chain D
3–370(368 aa)
|
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
|
EDO 1,2-ETHANEDIOL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;50 mM sodium cacodylate pH 6.5, 200 mM ammonium acetate and 10 mM calcium chloride and 10% (w/v) polyethylene glycol (PEG) 4000
|
Resolution 2.79 Å
R-free 0.266
|
|
7VN6
Crystal structure of MBP-fused BIL1/BZR1 (21-90) in complex with double-stranded DNA contaning CGCACGTGCG
Deposited 2021-10-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain A
3–370(368 aa)
Chain B
3–370(368 aa)
|
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
|
EDO 1,2-ETHANEDIOL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;50 mM sodium cacodylate pH 6.5, 200 mM ammonium acetate and 10 mM calcium chloride and 10% (w/v) polyethylene glycol (PEG) 4000
|
Resolution 2.79 Å
R-free 0.266
|
|
7VN7
Crystal structure of MBP-fused BIL1/BZR1 (21-90) in complex with double-stranded DNA contaning GACACGTGTC
Deposited 2021-10-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain C
3–370(368 aa)
Chain D
3–370(368 aa)
|
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
|
EDO 1,2-ETHANEDIOL × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;50 mM sodium cacodylate pH 6.5, 200 mM ammonium acetate and 10 mM calcium chloride and 10% (w/v) polyethylene glycol (PEG) 4000
|
Resolution 2.11 Å
R-free 0.244
|
|
7VN7
Crystal structure of MBP-fused BIL1/BZR1 (21-90) in complex with double-stranded DNA contaning GACACGTGTC
Deposited 2021-10-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain A
3–370(368 aa)
Chain B
3–370(368 aa)
|
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
|
EDO 1,2-ETHANEDIOL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;50 mM sodium cacodylate pH 6.5, 200 mM ammonium acetate and 10 mM calcium chloride and 10% (w/v) polyethylene glycol (PEG) 4000
|
Resolution 2.11 Å
R-free 0.244
|
|
7VN8
Crystal structure of MBP-fused BIL1/BZR1 (21-90) in complex with double-stranded DNA contaning GTCACGTGAC
Deposited 2021-10-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain C
3–370(368 aa)
Chain D
3–370(368 aa)
|
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
|
EDO 1,2-ETHANEDIOL × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;50 mM sodium cacodylate pH 6.5, 200 mM potassium chloride, 10 mM magnesium chloride and 10% (w/v) polyethylene glycol (PEG) 4000
|
Resolution 2.04 Å
R-free 0.240
|
|
7VN8
Crystal structure of MBP-fused BIL1/BZR1 (21-90) in complex with double-stranded DNA contaning GTCACGTGAC
Deposited 2021-10-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain A
3–370(368 aa)
Chain B
3–370(368 aa)
|
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
Mutation:D82A,K83A,E172A,N173A,K239A,E359A,K362A,D363A
|
EDO 1,2-ETHANEDIOL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;50 mM sodium cacodylate pH 6.5, 200 mM potassium chloride, 10 mM magnesium chloride and 10% (w/v) polyethylene glycol (PEG) 4000
|
Resolution 2.04 Å
R-free 0.240
|
|
8G3S
MBP-Mcl1 in complex with ligand 11
Deposited 2023-02-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–368(367 aa)
|
Not recorded
|
FMT FORMIC ACID × 2
YLT (1'S,3aS,5R,16R,17S,19E,21S,21aR)-6'-chloro-21-methoxy-16,17-dimethyl-2,3,3',3a,4',16,17,18,21,21a-decahydro-2'H,6H,8H-15lambda~6~-spiro[10,12-etheno-15lambda~6~-furo[3,2-i][1,4]oxazepino[3,4-f][1,2,7]thiadiazacyclohexadecine-7,1'-naphthalene]-13,15,15(4H,14H)-trione × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;285 K;0.17 M Mg Formate, 25.00% (w/v) PEG3350
|
Resolution 1.40 Å
R-free 0.194
|
|
8G3T
MBP-Mcl1 in complex with ligand 12
Deposited 2023-02-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–368(367 aa)
|
Not recorded
|
FMT FORMIC ACID × 1
EDO 1,2-ETHANEDIOL × 1
YLK (1'S,3aS,5R,16R,17S,19Z,21R,21aR)-6'-chloro-20-fluoro-21-methoxy-16,17-dimethyl-2,3,3',3a,4',16,17,18,21,21a-decahydro-2'H,6H,8H-15lambda~6~-spiro[10,12-etheno-15lambda~6~-furo[3,2-i][1,4]oxazepino[3,4-f][1,2,7]thiadiazacyclohexadecine-7,1'-naphthalene]-13,15,15(4H,14H)-trione × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;285 K;0.17M Mg Formate, 23.5% (w/v) PEG3350
|
Resolution 1.83 Å
R-free 0.233
|
|
8G3U
MBP-Mcl1 in complex with ligand 21
Deposited 2023-02-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–368(367 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 2
YKT (1'S,3aS,5R,16R,17S,19Z,21R,21aR)-6'-chloro-20-fluoro-21-{[(5S,9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]methyl}-21-methoxy-16,17-dimethyl-2,3,3',3a,4',16,17,18,21,21a-decahydro-2'H,6H,8H-15lambda~6~-spiro[10,12-(ethanediylidene)-15lambda~6~-furo[3,2-i][1,4]oxazepino[3,4-f][1,2,7]thiadiazacyclohexadecine-7,1'-naphthalene]-13,15,15(4H,14H)-trione × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;285 K;0.11 M Mg Formate, 19.0% (w/v) PEG3350
|
Resolution 1.94 Å
R-free 0.238
|
|
8G3W
MBP-Mcl1 in complex with ligand 28
Deposited 2023-02-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–368(367 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 3
PEG DI(HYDROXYETHYL)ETHER × 1
YKX N-[(1'S,3aS,5R,15S,17S,19Z,21R,21aR)-6'-chloro-20-fluoro-21-methoxy-17-methyl-13,15-dioxo-2,3,3',3a,4,4',13,16,17,18,21,21a-dodecahydro-2'H,6H,8H-15lambda~6~-spiro[10,12-(ethanediylidene)-15lambda~6~-furo[3,2-i][1,4]oxazepino[3,4-f][1,2,7]thiadiazacyclohexadecine-7,1'-naphthalen]-15-yl]-3-methoxy-1-methyl-1H-pyrazole-4-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;285 K;19% (w/v) PEG3350, 0.05 M Mg Formate
|
Resolution 1.78 Å
R-free 0.226
|
|
8G3X
MBP-Mcl1 in complex with ligand 32
Deposited 2023-02-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–368(367 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 10
YLF N-[(1'S,3aS,5R,15S,17S,19Z,21R,21aR)-6'-chloro-20-fluoro-21-{[(5S,9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]methyl}-21-methoxy-17-methyl-13,15-dioxo-2,3,3',3a,4,4',13,16,17,18,21,21a-dodecahydro-2'H,6H,8H-15lambda~6~-spiro[10,12-(ethanediylidene)-15lambda~6~-furo[3,2-i][1,4]oxazepino[3,4-f][1,2,7]thiadiazacyclohexadecine-7,1'-naphthalen]-15-yl]-3-methoxy-1-methyl-1H-pyrazole-4-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;285 K;20.5% (w/v) PEG3350, 0.11M Mg formate
|
Resolution 1.46 Å
R-free 0.206
|
|
8G3Y
MBP-Mcl1 in complex with ligand 34
Deposited 2023-02-08
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–368(367 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
EDO 1,2-ETHANEDIOL × 3
PEG DI(HYDROXYETHYL)ETHER × 1
YKL N-[(1'S,3aS,5R,15S,17S,19Z,21S,21aR)-6'-chloro-20-fluoro-21-{[(5S,9aS)-hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]methyl}-21-methoxy-17-methyl-13,15-dioxo-2,3,3',3a,4,4',13,16,17,18,21,21a-dodecahydro-2'H,6H,8H-15lambda~6~-spiro[10,12-(ethanediylidene)-15lambda~6~-furo[3,2-i][1,4]oxazepino[3,4-f][1,2,7]thiadiazacyclohexadecine-7,1'-naphthalen]-15-yl]-3-methoxy-1-methyl-1H-pyrazole-4-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 7.5;285 K;25% (w/v) PEG3350, 0.11M Mg formate
|
Resolution 1.70 Å
R-free 0.216
|
|
8R2O
Huntingtin-Q17, 1-66, N-MBP fusion
Deposited 2023-11-07
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
3–372(370 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.25;293 K;0.8 M KH2PO4, 0.8 M NaH2PO4,
and 0.1 M TRIS/HCl pH 8.25
|
Resolution 3.23 Å
R-free 0.238
|
|
8R2O
Huntingtin-Q17, 1-66, N-MBP fusion
Deposited 2023-11-07
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
3–372(370 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.25;293 K;0.8 M KH2PO4, 0.8 M NaH2PO4,
and 0.1 M TRIS/HCl pH 8.25
|
Resolution 3.23 Å
R-free 0.238
|
|
8R3E
Huntingtin, 1-17, MBP-N
Deposited 2023-11-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 6
PDB declaration: hexameric
|
Chain A
3–372(370 aa)
Chain B
3–372(370 aa)
Chain C
3–372(370 aa)
Chain D
3–372(370 aa)
Chain E
3–372(370 aa)
Chain F
3–372(370 aa)
|
Not recorded
|
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;20% (w/v) PEG 6K, 0.24 M Na2 malonate, 10mM ZnCl2 and 0.1 M MES-NaOH, pH6.0
|
Resolution 2.91 Å
R-free 0.329
|
|
8ZLW
Crystal Structure of RDGC IQ motif/dCaM Complex
Deposited 2024-05-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
3–371(369 aa)
|
Not recorded
|
CA CALCIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;289 K;2 % v/v Tacsimate pH 4.0, 0.1 M Sodium acetate trihydrate pH 4.6, 16 % w/v PEG 3350
|
Resolution 2.20 Å
R-free 0.254
|
|
9GRY
Cryo-EM structure of human SLC35B1-Q113F variant with AMP-PNP
Deposited 2024-09-13
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
2–370(369 aa)
|
Not recorded
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å
|
|
9GS3
Cryo-EM structure of human SLC35B1-E33A variant with ADP in inward facing conformation
Deposited 2024-09-13
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–370(369 aa)
|
Not recorded
|
ADP ADENOSINE-5'-DIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.15 Å
|
|
9I20
Cryo-EM structure of human SLC35B1 with ADP
Deposited 2025-01-17
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
2–370(369 aa)
|
Not recorded
|
ADP ADENOSINE-5'-DIPHOSPHATE × 1
PEV (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.85 Å
|
|
9M73
Crystal structure of MBP-fused BIL1/BZR1 (21-104) in complex with double-stranded DNA contaning CACATATGTG
Deposited 2025-03-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain C
3–371(369 aa)
Chain D
3–371(369 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;50 mM sodium cacodylate pH 6.5, 200 mM potassium chloride, 10 mM magnesium chloride and 10% (w/v) polyethylene glycol (PEG) 4000
|
Resolution 2.31 Å
R-free 0.245
|
|
9M73
Crystal structure of MBP-fused BIL1/BZR1 (21-104) in complex with double-stranded DNA contaning CACATATGTG
Deposited 2025-03-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain A
3–371(369 aa)
Chain B
3–371(369 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;50 mM sodium cacodylate pH 6.5, 200 mM potassium chloride, 10 mM magnesium chloride and 10% (w/v) polyethylene glycol (PEG) 4000
|
Resolution 2.31 Å
R-free 0.245
|
|
9M74
Crystal structure of MBP-fused BIL1/BZR1 (21-104) in complex with double-stranded DNA contaning CACAGCTGTG
Deposited 2025-03-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain C
3–371(369 aa)
Chain D
3–371(369 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;50 mM sodium cacodylate pH 6.5, 200 mM ammonium acetate and 10 mM calcium chloride and 10% (w/v) polyethylene glycol (PEG) 4000
|
Resolution 2.23 Å
R-free 0.244
|
|
9M74
Crystal structure of MBP-fused BIL1/BZR1 (21-104) in complex with double-stranded DNA contaning CACAGCTGTG
Deposited 2025-03-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Homooligomer;Protein × 2
PDB declaration: tetrameric
|
Chain A
3–371(369 aa)
Chain B
3–371(369 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;50 mM sodium cacodylate pH 6.5, 200 mM ammonium acetate and 10 mM calcium chloride and 10% (w/v) polyethylene glycol (PEG) 4000
|
Resolution 2.23 Å
R-free 0.244
|
|
9PW7
Myeloid cell leukemia-1 (Mcl-1) complexed with compound 13
Deposited 2025-08-04
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–368(367 aa)
|
Not recorded
|
A1CL6 (2S,4R,5S,12P,23R)-11-chloro-7-[3-(4-chloro-3,5-dimethylphenoxy)propyl]-27,28-dimethoxy-4,15-dimethyl-32-oxo-19-oxa-2,5,15,16,23-pentaazaheptacyclo[21.6.1.1~2,6~.1~5,8~.0~12,31~.0~13,17~.0~26,30~]dotriaconta-1(30),6,8(31),9,11,13,16,24,26,28-decaene-24-carboxylic acid (non-preferred name) × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;291 K;25-30% PEG3350, 0.1 M Bis-TRIS pH 6.5, 0.2 M MgCl2
|
Resolution 1.95 Å
R-free 0.223
|